The rise of artificial intelligence has led to breakthroughs across a number of industries, including healthcare and medical technology. RapidAI combines medical imaging with artificial intelligence to deliver a range of solutions for combatting life-threatening vascular and neurovascular conditions more effectively.
Through the company's scalable and secure platform, hospitals can make better and faster clinical decisions surrounding stroke, aneurysm, pulmonary embolism and, most recently, intracranial haemorrhage. Built on intelligence gained from over 10 million scans, RapidAI brings a level of visibility never before possible, supporting doctors to improve health outcomes for their patients.
The company is extremely well-regarded in the space, and has won awards such as the 2023 MedTech Breakthrough Award for Best New Imaging Solution. It recently announced the raise of $75 million in growth investment which will be used to drive platform innovation towards supporting more conditions, as well as fund go-to-market functions to accelerate growth in new regions and product verticals.
Steph
Company Specialist at Welcome to the Jungle